ALT vs REGN: Which Stock is Better?
Side-by-side comparison of Altimmune Inc and Regeneron Pharmaceuticals Inc in 2026
ALT
Altimmune Inc
$3.80
REGN
Regeneron Pharmaceuticals Inc
$746.61
Key Metrics Comparison
| Metric | ALT | REGN | Winner |
|---|---|---|---|
| Market Cap | $483.39M | $81.90B | REGN |
| P/E Ratio | N/A | 18.69 | REGN |
| EPS (TTM) | $N/A | $41.44 | REGN |
| Revenue Growth | 4.2% | 0.0% | ALT |
| Gross Margin | -161929.3% | 44.6% | REGN |
Analyze ALT
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ALT or REGN a better investment?
Comparing ALT and REGN: Altimmune Inc has a market cap of $483.39M while Regeneron Pharmaceuticals Inc has $81.90B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ALT and REGN?
ALT (Altimmune Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ALT or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ALT or REGN?
ALT has higher revenue growth at 4.2% vs 0.0% for REGN.
Which company is more profitable: ALT or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -161929.3% for ALT.
Which is the larger company: ALT or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $81.90B compared to $483.39M for ALT.
Should I buy ALT or REGN in 2026?
Both ALT and REGN have investment merit. ALT trades at $3.80 while REGN trades at $746.61. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ALT and REGN stock?
Key differences: Market Cap ($483.39M vs $81.90B), P/E Ratio (N/A vs 18.7x), Revenue Growth (4.2% vs 0.0%), Gross Margin (-161929.3% vs 44.6%).